Concepedia

Author

Ingo G.H. Schmidt‐Wolf

University of Bonn

Also Known As

Angela M�rten, H-A Horst, I G H Schmidt-Wolf, I G Schmidt-Wolf, I Schmidt-Wolf, I. G. H. Schmidt-Wolf, I. G. H. Schmidt‐Wolf, I. G. Schmidt-Wolf, I. SCHMIDT‐WOLF, I. Schmidt-Wolf

318

Publications

14.3K

Citations

56

H-Index

120

Concepts

All Affiliations

University of BonnUniversity Hospital BonnHeidelberg UniversityHochschule Bonn-Rhein-SiegUniversity of Cologne
IG

About

Ingo G.H. Schmidt‐Wolf is an author at University of Bonn specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

47

2.9K

2

Cell Biology

18

26

1.5K

3

Health Sciences

11

11

938

4

Public Health

1

1

41

5

Blood Transplantation

1

1

11

Ingo G.H. Schmidt‐Wolf

×

136

Publications

11.8K

Citations

49

H-Index

YearCitations

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Gary R. Hudes, Michael A. Carducci, Piotr Tomczak,

New England Journal of Medicine

2007

3.6K

<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

Verena I. Gaidzik, Lars Bullinger, Richard F. Schlenk,

Journal of Clinical Oncology

2011

449

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

Hendrik Pels, Ingo G.H. Schmidt‐Wolf, Axel Glasmacher,

Journal of Clinical Oncology

2003

420

Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

Anjali S. Advani, Bertrand Coiffier, Myron S. Czuczman,

Journal of Clinical Oncology

2010

329

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

Ingo G.H. Schmidt‐Wolf, Petja Lefterova, Bela Mehta,

PubMed

1993

328

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Dieter Hoelzer, Jan Walewski, Hartmut Döhner,

Blood

2014

296

High <i>EVI1</i> Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities

Stefan Gröschel, Sanne Lugthart, Richard F. Schlenk,

Journal of Clinical Oncology

2010

259

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

C. Hontscha, Yvonne Borck, Hui Zhou,

Journal of Cancer Research and Clinical Oncology

2010

212

Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate

H. Palmedo, Agnieska Manka-Waluch, Peter Albers,

Journal of Clinical Oncology

2003

158

<i>Clostridium difficile</i>Infection in Patients with Neutropenia

Marcus Gorschlüter, Axel Glasmacher, Corinna Hahn,

Clinical Infectious Diseases

2001

155

Page 1